VeonGen Therapeutics
PrivateLast Round
Series A
Nov 28, 2019
Company Overview
VeonGen Therapeutics is a biotechnology company that develops innovative gene therapies for ophthalmic diseases and other genetic conditions using proprietary adeno-associated virus (AAV) technology platforms.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
VeonGen Therapeutics Comparables
Compare VeonGen Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ray Therapeutics | 78% | |
| Ascidian Therapeutics | 75% | |
| Cure Genetics | 74% | |
VeonGen Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Nov 28, 2019 |
VeonGen Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ludwig-Maximilians-Universität München | Series A |
| HongShan Capital Group (HSG) | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 15, 2026
Monthly visitors increased 224% MoM.
- Apr 5, 2026
Monthly visitors increased 73% MoM.
VeonGen Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about VeonGen Therapeutics's valuation, stock price, and market status.